Sensitization of Drug Resistant Cancer Cells: A Matter of Combination Therapy
Cancer drug resistance is an enormous problem. It is responsible for most relapses in cancer patients following apparent remission after successful therapy. Understanding cancer relapse requires an understanding of the processes underlying cancer drug resistance. This article discusses the causes of...
Main Authors: | Meghan Leary, Sarah Heerboth, Karolina Lapinska, Sibaji Sarkar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-12-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/10/12/483 |
Similar Items
-
Drug Resistance in Cancer: An Overview
by: Genevieve Housman, et al.
Published: (2014-09-01) -
Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
by: Gloria Manzotti, et al.
Published: (2019-03-01) -
From Bench to Bedside: Targeting Epigenetics for Cancer Therapy
by: Jin-xu Fang, et al.
Published: (2011-12-01) -
Drugs Targeting Epigenetic Modifications and Plausible Therapeutic Strategies Against Colorectal Cancer
by: Srinivas Patnaik, et al.
Published: (2019-06-01) -
Dietary Compounds as Epigenetic Modulating Agents in Cancer
by: Ángeles Carlos-Reyes, et al.
Published: (2019-03-01)